Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exelixis
Genelux Corporation
University of California, San Francisco
Grupo Español de Investigación en Cáncer de Ovario
Hoffmann-La Roche
MultiVir, Inc.